Potassium binders as enablers of guideline‐directed renin–angiotensin–aldosterone system inhibitor therapy
Journal of Internal Medicine · 2026-08 · 300 (2) · 106-109
DOI: 10.1111/joim.70100 ↗At a glance
Editorial in Journal of Internal Medicine, published online on 2026-05-18. Written by Carmine Zoccali and 1 co-authors. Institution: Renal Research Institute, New York, New York, USA. 12 references.
Abstract (original language)
Ebda abstract disponibbli.
Authors and institutions
- Renal Research Institute, New York, New York, USA.
- Institute of Molecular Biology and Genetics (Biogem), Ariano Irpino, Italy.
- Associazione Ipertensione Nefrologia Trapianto Renal (IPNET), Reggio Calabria, Italy.
ORCID profiles: Carmine Zoccali, Francesca Mallamaci
Cite
APA
Zoccali, C., & Mallamaci, F. (2026). Potassium binders as enablers of guideline‐directed renin–angiotensin–aldosterone system inhibitor therapy. Journal of Internal Medicine, 300(2), 106-109. https://doi.org/10.1111/joim.70100
Vancouver
Zoccali C, Mallamaci F. Potassium binders as enablers of guideline‐directed renin–angiotensin–aldosterone system inhibitor therapy. Journal of Internal Medicine. 2026;300(2):106-109. doi:10.1111/joim.70100
BibTeX
@article{Zoccali2026,
author = {Zoccali, Carmine and Mallamaci, Francesca},
title = {Potassium binders as enablers of guideline‐directed renin–angiotensin–aldosterone system inhibitor therapy},
journal = {Journal of Internal Medicine},
year = {2026},
volume = {300},
number = {2},
pages = {106--109},
doi = {10.1111/joim.70100}
}
EUVIMED